logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9266921 B1

PDFFull Text
Date of Patent:
Feb. 23, 2016

Filed:

Mar. 23, 2012

Pgc-1α-modulating peptides

Applicants:

José María García Antón, Barcelona, ES;

Nuria Almiñana Domenech, Barcelona, ES;

Antonio Vicente Ferrer Montiel, Alicante, ES;

Inventors:

José María García Antón, Barcelona, ES;

Nuria Almiñana Domenech, Barcelona, ES;

Antonio Vicente Ferrer Montiel, Alicante, ES;

Assignee:

Lipotec, S.A., Gava, Barcelona, ES;

Attorney:

Fay Sharpe LLP

Primary Examiner:

Karlheinz R Skowronek

Assistant Examiner:

Sergio Coffa

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/08 (2006.01); A61K 38/28 (2006.01); A61P 3/10 (2006.01); A61P 7/12 (2006.01); A61P 9/12 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C07K 7/06 (2006.01); A61K 36/896 (2006.01); A61K 38/01 (2006.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); A61K 36/23 (2006.01); A61K 36/25 (2006.01); A61K 36/53 (2006.01); A61K 36/736 (2006.01); A61K 36/74 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 36/23 (2013.01); A61K 36/25 (2013.01); A61K 36/53 (2013.01); A61K 36/736 (2013.01); A61K 36/74 (2013.01); A61K 36/896 (2013.01); A61K 38/011 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 38/00 (2013.01);
Abstract

Peptides of general formula (I): R—W—X-AA-AA-AA-AA-AA-AA-Y—Z—Rtheir stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1α modulation.R—W—X-AA-AA-AA-AA-AA-AA-Y—Z—R  (I)

Find Patent Forward Citations

Loading…